27.54 USD
↗ 1.69 (6.54%)AT CLOSE (11:59 AM EDT)
Parabilis Medicines, Inc. Common Stock
PBLSNASDAQ • USD
28.28
↗ 0.73 (2.67%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
28.28
↗ 0.73 (2.67%)
Market: CLOSED
Shares of Parabilis Medicines, Inc. Common Stock (PBLS) are trading at $27.53. The technical outlook is "Neutral" based on moving average alignment, RSI, and MACD signals. This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Jun 22, 2026.
Open?$26.00
High?$28.06
Low?$25.56
Prev. Close?$25.85
Volume?831.1K
Avg. Volume?N/A
VWAP?$27.45
Bid / Ask
Bid?$23.31 × 100
Ask?$32.91 × 100
Spread?$9.60
Midpoint?$28.11
Valuation & Ratios
Market Cap?3.2B
Shares Out?117.2M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short Interest
Loading...